Physician profile
Wanda Mott
NPI 1235124546
$1,024.40
in general payments reported to CMS, 2019-2025
17 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $75.16 · 2021: $129 · 2022: $151 · 2023: $124 · 2024: $82.79 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $173.11 | 2019-2022 | |
| Exeltis, USA INC. | $155.18 | 2019-2024 | Slynd |
| Minerva Surgical, INC | $132.40 | 2019 | |
| Astellas Pharma US INC | $118.85 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $82.72 | 2019-2023 | Affirm Prone Biopsy System |
| Viiv Healthcare Company | $64.47 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.64 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $41.71 | 2019 | |
| Organon LLC | $37.74 | 2021-2023 | Nexplanon |
| Mayne Pharma Commercial LLC | $28.40 | 2022 | |
| Myovant Sciences INC. | $24.97 | 2022 | |
| Allergan, INC. | $23.90 | 2019-2020 | |
| Duchesnay USA Incorporated | $20.67 | 2019 | |
| Sumitomo Pharma America, INC. | $17.89 | 2024 | Myfembree |
| Amgen INC. | $13.89 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $13.16 | 2022 | |
| Coopersurgical, INC. | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Mott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.